Literature DB >> 7811042

Antibiotic resistance and penicillin tolerance in clinical isolates of group B streptococci.

C Betriu1, M Gomez, A Sanchez, A Cruceyra, J Romero, J J Picazo.   

Abstract

The aim of this study was to determine the susceptibility patterns of 100 group B streptococcal strains isolated in our hospital and to ascertain tolerance to penicillin by determining quantitative killing curves. We found two strains with intermediate susceptibility to penicillin and eight strains to ampicillin. Seventeen isolates were tolerant to penicillin, with bacterial counts decreasing 2 to 3 log during the first 8 h but still above 10(2) CFU/ml after 24 h. The kinetic study shows that penicillin tolerance is not rare among group B streptococci isolated in our hospital.

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7811042      PMCID： PMC284707          DOI： 10.1128/AAC.38.9.2183

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  35 in total

1.  Degree and stability of tolerance to penicillin in Streptococcus pyogenes.

Authors:  M F Michel; W B van Leeuwen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-03       Impact factor: 3.267

Review 2.  Antibiotic tolerance among clinical isolates of bacteria.

Authors:  E Tuomanen; D T Durack; A Tomasz
Journal:  Antimicrob Agents Chemother       Date:  1986-10       Impact factor: 5.191

Review 3.  Problems in in vitro determination of antibiotic tolerance in clinical isolates.

Authors:  J C Sherris
Journal:  Antimicrob Agents Chemother       Date:  1986-11       Impact factor: 5.191

Review 4.  Antibiotic tolerance among clinical isolates of bacteria.

Authors:  S Handwerger; A Tomasz
Journal:  Rev Infect Dis       Date:  1985 May-Jun

5.  Penicillin tolerance in group B streptococci.

Authors:  A Broadbent
Journal:  J Antimicrob Chemother       Date:  1984-04       Impact factor: 5.790

6.  Susceptibility of group B streptococci to 16 beta-lactam antibiotics, including new penicillin and cephalosporin derivatives.

Authors:  M R Jacobs; F Kelly; W T Speck
Journal:  Antimicrob Agents Chemother       Date:  1982-11       Impact factor: 5.191

7.  Synergy between penicillins and low concentrations of gentamicin in the killing of group B streptococci.

Authors:  H M Swingle; R L Bucciarelli; E M Ayoub
Journal:  J Infect Dis       Date:  1985-09       Impact factor: 5.226

8.  [Antibiotic sensitivity of Streptococcus group B].

Authors:  J C Borderon; E Borderon; P Geslin; G Sissia; M Valla
Journal:  Pathol Biol (Paris)       Date:  1984-01

9.  Determination of minimum bactericidal concentrations of oxacillin for Staphylococcus aureus: influence and significance of technical factors.

Authors:  P C Taylor; F D Schoenknecht; J C Sherris; E C Linner
Journal:  Antimicrob Agents Chemother       Date:  1983-01       Impact factor: 5.191

10.  Group B streptococcal cellulitis in an adult.

Authors:  D Stampfl; A Verghese; T Parrino
Journal:  Postgrad Med       Date:  1985-04       Impact factor: 3.840
View more
  18 in total

1.  Antibiotic susceptibility and mechanisms of erythromycin resistance in clinical isolates of Streptococcus agalactiae: French multicenter study.

Authors:  D De Mouy; J D Cavallo; R Leclercq; R Fabre
Journal:  Antimicrob Agents Chemother       Date:  2001-08       Impact factor: 5.191

2.  High incidence of erythromycin resistance among clinical isolates of Streptococcus agalactiae in Taiwan.

Authors:  P R Hsueh; L J Teng; L N Lee; S W Ho; P C Yang; K T Luh
Journal:  Antimicrob Agents Chemother       Date:  2001-11       Impact factor: 5.191

3.  Antimicrobial susceptibilities of group B streptococci isolated between 1992 and 1996 from patients with bacteremia or meningitis.

Authors:  M Fernandez; M E Hickman; C J Baker
Journal:  Antimicrob Agents Chemother       Date:  1998-06       Impact factor: 5.191

4.  Colonization rates and serotypes of group B streptococci isolated from pregnant women in a Korean tertiary hospital.

Authors:  Y Uh; I H Jang; K J Yoon; C H Lee; J Y Kwon; M C Kim
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-10       Impact factor: 3.267

5.  Identification and molecular analysis of PcsB, a protein required for cell wall separation of group B streptococcus.

Authors:  D J Reinscheid; B Gottschalk; A Schubert; B J Eikmanns; G S Chhatwal
Journal:  J Bacteriol       Date:  2001-02       Impact factor: 3.490

6.  Ampicillin susceptibilities of vaginal and placental isolates of group B streptococcus and Escherichia coli obtained between 1992 and 1994.

Authors:  L A Meyn; S L Hillier
Journal:  Antimicrob Agents Chemother       Date:  1997-05       Impact factor: 5.191

7.  Antibiotic susceptibility in neonatal invasive isolates of Streptococcus agalactiae in a 2-year nationwide surveillance study in Germany.

Authors:  Kirsten Fluegge; Sven Supper; Anette Siedler; Reinhard Berner
Journal:  Antimicrob Agents Chemother       Date:  2004-11       Impact factor: 5.191

8.  Cadaverine suppresses persistence to carboxypenicillins in Pseudomonas aeruginosa PAO1.

Authors:  Jerrylynn Manuel; George G Zhanel; Teresa de Kievit
Journal:  Antimicrob Agents Chemother       Date:  2010-09-20       Impact factor: 5.191

9.  Novel mutations in a patient isolate of Streptococcus agalactiae with reduced penicillin susceptibility emerging after long-term oral suppressive therapy.

Authors:  Jean Longtin; Christie Vermeiren; Dea Shahinas; Gurdip Singh Tamber; Allison McGeer; Donald E Low; Kevin Katz; Dylan R Pillai
Journal:  Antimicrob Agents Chemother       Date:  2011-03-07       Impact factor: 5.191

10.  DNA microarray-based typing of Streptococcus agalactiae isolates.

Authors:  Heike Nitschke; Peter Slickers; Elke Müller; Ralf Ehricht; Stefan Monecke
Journal:  J Clin Microbiol       Date:  2014-08-27       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.